Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Ovintiv Inc ha un obiettivo di prezzo di consenso pari a $52.11, stabilito in base alle ultime valutazioni degli analisti di 19. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, RBC Capital y Roth Capital il octubre 17, 2025, octubre 15, 2025 y octubre 14, 2025. Con un obiettivo di prezzo medio di $45 tra le Wells Fargo, RBC Capital y Roth Capital, c'è un implicito 25.10% upside per Ovintiv Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
10/17/2025 | 5.64% | Wells Fargo | $46 → $38 | Maintains | Equal-Weight | |||
10/15/2025 | 52.91% | RBC Capital | $55 → $55 | Upgrade | Sector Perform → Outperform | |||
10/14/2025 | 16.76% | Roth Capital | → $42 | Initiates | → Neutral | |||
10/14/2025 | 27.88% | Morgan Stanley | $48 → $46 | Maintains | Equal-Weight | |||
10/07/2025 | 52.91% | Barclays | $57 → $55 | Maintains | Overweight | |||
10/06/2025 | 19.54% | Evercore ISI Group | $42 → $43 | Maintains | Outperform | |||
10/03/2025 | 30.66% | JP Morgan | $50 → $47 | Maintains | Overweight | |||
09/15/2025 | 39% | Mizuho | $58 → $50 | Maintains | Outperform | |||
08/20/2025 | 44.56% | UBS | $51 → $52 | Maintains | Buy | |||
08/18/2025 | 33.44% | Morgan Stanley | $52 → $48 | Downgrade | Overweight → Equal-Weight | |||
07/28/2025 | 39% | JP Morgan | $46 → $50 | Maintains | Overweight | |||
07/25/2025 | 58.47% | Barclays | $55 → $57 | Maintains | Overweight | |||
07/11/2025 | 41.78% | Scotiabank | $48 → $51 | Maintains | Sector Outperform | |||
07/07/2025 | 52.91% | Barclays | $53 → $55 | Maintains | Overweight | |||
07/01/2025 | 41.78% | Goldman Sachs | $47 → $51 | Upgrade | Neutral → Buy | |||
06/16/2025 | 13.98% | Wells Fargo | $46 → $41 | Maintains | Equal-Weight | |||
05/13/2025 | 61.25% | Mizuho | $60 → $58 | Maintains | Outperform | |||
04/23/2025 | 47.35% | Barclays | $59 → $53 | Maintains | Overweight | |||
04/22/2025 | 27.88% | Wells Fargo | $45 → $46 | Maintains | Equal-Weight | |||
04/15/2025 | 39% | Morgan Stanley | $57 → $50 | Maintains | Overweight | |||
03/26/2025 | 58.47% | Morgan Stanley | → $57 | Reinstates | → Overweight | |||
03/20/2025 | 25.1% | Wells Fargo | $44 → $45 | Maintains | Equal-Weight | |||
03/13/2025 | 25.1% | JP Morgan | $56 → $45 | Maintains | Overweight | |||
01/30/2025 | 64.03% | Barclays | $57 → $59 | Maintains | Overweight | |||
01/13/2025 | 66.81% | Truist Securities | $59 → $60 | Maintains | Buy | |||
01/13/2025 | 50.13% | B of A Securities | $55 → $54 | Upgrade | Neutral → Buy | |||
12/17/2024 | 16.76% | Wells Fargo | $48 → $42 | Maintains | Equal-Weight | |||
12/16/2024 | 66.81% | Mizuho | $63 → $60 | Maintains | Outperform | |||
12/09/2024 | 55.69% | UBS | $59 → $56 | Maintains | Buy | |||
12/06/2024 | 41.78% | JP Morgan | $54 → $51 | Maintains | Overweight | |||
11/26/2024 | 50.13% | Citigroup | $55 → $54 | Maintains | Buy | |||
11/18/2024 | 64.03% | UBS | $57 → $59 | Maintains | Buy | |||
11/18/2024 | 47.35% | Scotiabank | $50 → $53 | Maintains | Sector Outperform | |||
11/15/2024 | 64.03% | Truist Securities | $57 → $59 | Maintains | Buy | |||
11/15/2024 | 58.47% | Barclays | $53 → $57 | Maintains | Overweight | |||
10/09/2024 | 61.25% | Mizuho | $60 → $58 | Maintains | Outperform | |||
10/07/2024 | 52.91% | Citigroup | $58 → $55 | Maintains | Buy | |||
10/01/2024 | 16.76% | Wells Fargo | $51 → $42 | Maintains | Equal-Weight | |||
09/30/2024 | 50.13% | Evercore ISI Group | $60 → $54 | Maintains | Outperform | |||
09/30/2024 | 30.66% | Truist Securities | $62 → $47 | Maintains | Buy | |||
09/18/2024 | 58.47% | UBS | $61 → $57 | Maintains | Buy | |||
09/16/2024 | 41.78% | Morgan Stanley | $53 → $51 | Maintains | Equal-Weight | |||
09/12/2024 | 41.78% | JP Morgan | $60 → $51 | Maintains | Overweight | |||
08/09/2024 | 69.59% | UBS | $66 → $61 | Maintains | Buy | |||
08/01/2024 | 69.59% | RBC Capital | $62 → $61 | Maintains | Sector Perform | |||
08/01/2024 | 72.37% | Truist Securities | $60 → $62 | Maintains | Buy | |||
08/01/2024 | 41.78% | Wells Fargo | $52 → $51 | Maintains | Equal-Weight | |||
07/22/2024 | 66.81% | Truist Securities | $68 → $60 | Maintains | Buy | |||
07/22/2024 | 44.56% | Wells Fargo | $54 → $52 | Maintains | Equal-Weight | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Outperform | |||
07/12/2024 | 66.81% | Scotiabank | $58 → $60 | Maintains | Sector Outperform | |||
07/10/2024 | 66.81% | Evercore ISI Group | $60 → $60 | Reiterates | Outperform → Outperform | |||
06/14/2024 | 52.91% | B of A Securities | → $55 | Reinstates | → Neutral | |||
06/14/2024 | 66.81% | Evercore ISI Group | $60 → $60 | Upgrade | In-Line → Outperform | |||
06/10/2024 | 83.49% | TD Cowen | $64 → $66 | Maintains | Buy | |||
05/15/2024 | 94.61% | UBS | $69 → $70 | Maintains | Buy | |||
05/13/2024 | 77.93% | Mizuho | $58 → $64 | Maintains | Buy | |||
04/15/2024 | 47.35% | Morgan Stanley | $49 → $53 | Maintains | Equal-Weight | |||
04/12/2024 | 91.83% | Jefferies | $59 → $69 | Maintains | Buy | |||
04/11/2024 | 91.83% | UBS | $62 → $69 | Maintains | Buy | |||
04/10/2024 | 91.83% | Barclays | → $69 | Initiates | → Overweight | |||
04/04/2024 | 61.25% | Mizuho | $58 → $58 | Reiterates | Buy → Buy | |||
03/28/2024 | 36.22% | Morgan Stanley | $48 → $49 | Maintains | Equal-Weight | |||
03/26/2024 | 55.69% | Goldman Sachs | $47 → $56 | Maintains | Neutral | |||
03/22/2024 | 61.25% | Mizuho | $59 → $58 | Maintains | Buy | |||
03/18/2024 | 61.25% | Citigroup | $52 → $58 | Maintains | Buy | |||
03/12/2024 | 50.13% | Wells Fargo | $44 → $54 | Maintains | Equal-Weight | |||
02/29/2024 | 55.69% | JP Morgan | $54 → $56 | Maintains | Overweight | |||
02/29/2024 | 36.22% | RBC Capital | $48 → $49 | Maintains | Sector Perform | |||
12/14/2023 | 58.47% | UBS | $63 → $57 | Maintains | Buy | |||
12/06/2023 | 61.25% | JP Morgan | $61 → $58 | Upgrade | Neutral → Overweight | |||
11/22/2023 | 36.22% | Wells Fargo | $51 → $49 | Maintains | Equal-Weight | |||
11/22/2023 | 44.56% | Citigroup | $48 → $52 | Upgrade | Neutral → Buy | |||
10/20/2023 | 41.78% | Wells Fargo | $47 → $51 | Maintains | Equal-Weight | |||
10/17/2023 | 36.22% | Morgan Stanley | $47 → $49 | Maintains | Equal-Weight | |||
10/04/2023 | 77.93% | UBS | $62 → $64 | Maintains | Buy | |||
10/02/2023 | 30.66% | Morgan Stanley | $46 → $47 | Maintains | Equal-Weight | |||
09/18/2023 | 86.27% | Mizuho | $65 → $67 | Maintains | Buy | |||
08/18/2023 | 27.88% | Morgan Stanley | $44 → $46 | Maintains | Equal-Weight | |||
08/17/2023 | 72.37% | UBS | $47 → $62 | Maintains | Buy | |||
08/16/2023 | 80.71% | Mizuho | $62 → $65 | Maintains | Buy | |||
08/01/2023 | 33.44% | Citigroup | $40 → $48 | Maintains | Neutral | |||
07/31/2023 | 50.13% | Truist Securities | $52 → $54 | Maintains | Buy | |||
07/31/2023 | 30.66% | RBC Capital | $46 → $47 | Maintains | Sector Perform | |||
07/18/2023 | 22.32% | Morgan Stanley | → $44 | Reinstates | → Equal-Weight | |||
07/13/2023 | 30.66% | UBS | $46 → $47 | Maintains | Buy | |||
07/12/2023 | 5.64% | Goldman Sachs | → $38 | Reinstates | → Neutral | |||
07/11/2023 | 11.2% | Citigroup | → $40 | Reiterates | Neutral → Neutral | |||
07/07/2023 | 8.42% | Wells Fargo | $36 → $39 | Maintains | Equal-Weight | |||
06/12/2023 | 72.37% | Mizuho | → $62 | Reiterates | Buy → Buy | |||
05/23/2023 | 39% | CIBC | $55 → $50 | Maintains | Neutral | |||
05/19/2023 | 72.37% | Mizuho | $66 → $62 | Maintains | Buy | |||
05/12/2023 | 0.08% | Wells Fargo | $40 → $36 | Maintains | Equal-Weight | |||
05/11/2023 | 33.44% | RBC Capital | → $48 | Reiterates | Sector Perform → Sector Perform | |||
04/19/2023 | 44.56% | UBS | → $52 | Assumes | → Buy | |||
04/17/2023 | 11.2% | Wells Fargo | $64 → $40 | Downgrade | Overweight → Equal-Weight | |||
04/11/2023 | 69.59% | Truist Securities | $56 → $61 | Maintains | Buy | |||
04/05/2023 | 47.35% | TD Cowen | $79 → $53 | Maintains | Outperform | |||
04/04/2023 | 16.76% | Evercore ISI Group | $60 → $42 | Maintains | In-Line | |||
04/04/2023 | 52.91% | RBC Capital | $57 → $55 | Maintains | Sector Perform |
El último precio objetivo de Ovintiv (NYSE:OVV) fue comunicado por Wells Fargo el octubre 17, 2025. La firma de analistas fijó un precio objetivo para $38.00 que espera OVV a rise dentro de 12 meses (un posible 5.64% upside). 35 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Ovintiv (NYSE:OVV) fue proporcionada por Wells Fargo, y Ovintiv mantuvo su equal-weight calificación.
La última revisión al alza de Ovintiv Inc se produjo en octubre 15, 2025, cuando RBC Capital elevó su precio objetivo a $55. RBC Capital anteriormente tenía a sector perform para Ovintiv Inc.
La última revisión a la baja de Ovintiv Inc se produjo en agosto 18, 2025, cuando Morgan Stanley cambió su precio objetivo de $52 a $48 para Ovintiv Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Ovintiv, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Ovintiv se registró el octubre 17, 2025, por lo que la próxima calificación estará disponible en torno al octubre 17, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Ovintiv (OVV) fue un mantuvo con un precio objetivo de $46.00 a $38.00. El precio actual al que cotiza Ovintiv (OVV) es de $35.97, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.